Muir of Ord, United Kingdom

Michael O'Connell

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Michael O'Connell

Introduction

Michael O'Connell is an accomplished inventor based in Muir of Ord, GB. He has made significant contributions to the field of analytical test strips, particularly in the development of enzymatic reagent inks. With a total of two patents to his name, O'Connell's work has the potential to enhance the accuracy and efficiency of glucose testing.

Latest Patents

O'Connell's latest patents include "Enzymatic reagent inks for use in test strips having a predetermined calibration code" and "Method for manufacturing an enzymatic reagent ink." The first patent provides an enzyme ink that allows for a test strip bias at both low and high glucose levels, ensuring results fall within a desired target range. This innovation improves the production method for single calibration code strip lots, yielding better results. The second patent outlines a method for manufacturing an enzymatic reagent ink, which involves determining relationships between the wetability of hydrophobic silica materials and calibration characteristics of analytical test strips. This method aims to optimize the formulation of the ink to achieve acceptable calibration characteristics.

Career Highlights

O'Connell is currently employed at Lifescan Scotland Limited, where he continues to innovate in the field of medical diagnostics. His work focuses on enhancing the performance of test strips used for glucose monitoring, which is crucial for individuals managing diabetes.

Collaborations

Some of O'Connell's notable coworkers include Marco Fabio Cardosi and Gary Young. Their collaborative efforts contribute to the advancement of technologies in the field of analytical testing.

Conclusion

Michael O'Connell's contributions to the development of enzymatic reagent inks and methods for their production represent significant advancements in glucose testing technology. His work at Lifescan Scotland Limited continues to impact the medical diagnostics field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…